Progenity, Inc.

4330 La Jolla Village Dr
San Diego
United States

Tel: 248-536-6243


Show jobs for this employer

1 article with Progenity, Inc.

  • Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that Harry Stylli, Ph.D., CEO, chairman of the board, and co-founder of Progenity, is scheduled to participate in two upcoming virtual investor conferences: A presentation at Baird’s 2020 Global Healthcare Conference at 12:15 p.m. ET / 9:15 a.m. PT on September 9, 202